Lumera Announces Shipment of Production Devices to Multiple Customers
During the past six months, Lumera has received orders for electro-optic modulators from Raytheon, undisclosed defense contractors and government agencies. Additionally, a semiconductor chip company ordered modulators to evaluate for board level and chip level optical interconnects.
“It is a measurement of our evolution from a world class research company to one that is delivering viable commercial products into the marketplace.”
"Today is another important milestone for Lumera," said Lumera Chief Executive Officer Tom Mino. "It is a measurement of our evolution from a world class research company to one that is delivering viable commercial products into the marketplace."
Lumera is using proprietary nanotechnology to develop unique materials addressing several multi-billion dollar marketplaces. Lumera is currently developing products for the optical/telecommunications, and the bioscience/biotech marketplaces.
"We continue to see significant revenue opportunities for our proprietary products and technology," continued Mino. "We view the shipping of products as positive evidence of our ability to pursue these opportunities."
Lumera is an emerging leader in the field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for a broad range of electro-optic, bioscience, RF and specialty nanotechnology applications. The company also has developed proprietary processes for fabricating such devices. For more information, please visit www.lumera.com
Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company's SEC reports, including its Annual Report on Form 10-K, and its Quarterly Reports on Form 10-Q.